Educational Resources

The Time Back campaign for cancer care honors oncologists, the emotional burdens they carry, and the work they do to help make more moments possible for people living with cancer.

Sacituzumab Govitecan plus Pembrolizumab for Advanced Triple-Negative Breast Cancer

ASCENT-04 published in New England Journal of Medicine: https://www.nejm.org/doi/full/10.1056/NEJMoa2508959

Sacituzumab Govitecan in Untreated, Advanced Triple-Negative Breast Cancer

ASCENT-03 published in New England Journal of Medicine: https://www.nejm.org/doi/full/10.1056/NEJMoa2511734

This brochure from Regeneron provides helpful information on advanced CSCC and advanced BCC in patients of color.

Joint initiative to focus on expanding early detection and equitable access to care through lung cancer specific AI workflows on Microsoft’s suite of radiology solutions. View the full press release.

Study marks the first positive Phase 3 study for mezigdomide and the second positive Phase 3 study for the Bristol Myers Squibb CELMoD program. View the full press release.

Posted on 11/12/2025

In addition to surgery, with the evolution of new treatment options, surgeons play a role in referral of patients to medical oncologists or the multidisciplinary team. Coordination with the medical oncologist and the entire care team can help facilitate the development of a treatment plan for patients. The resource will review some factors that may be relevant when considering neoadjuvant and adjuvant therapies.

Published on: February 17, 2025 Watch Dr. David Sallman, a leading MDS specialist at the Moffitt Cancer Center, talk about the importance of investigating unexplained anemia.

Posted on 10/16/2024

Hosted by Dr Javier Cortés and Prof. Peter Schmid, joined by an international panel of experts in ADCs and breast cancer, this educational podcast series unveils invaluable insights into ADCs, shedding light on their developmental history, their distinctive structural features and mechanisms of action, as well as potential future advancements.

Posted on 10/16/2024

Published on: July 15, 2024

Gilead Oncology understands that metastatic breast cancer (MBC) is different from early breast cancer in many ways. Expose MBC is a platform for patients and their caregivers, friends, and family to share and gain honest information about their experiences, as well as to find resources, support, and community to help live their unique reality.

Visit http://Expose-MBC.com and share this site with your patients.

Published on: Mar 24, 2024

This resource was created by Patient Resource and GO2 for Lung Cancer and produced with support from Jazz Pharmaceuticals to provide patients and their loved ones with comprehensive information to guide them throughout their journey with small cell lung cancer. A Spanish-speaking version is available via download. Free copies of this resource can be obtained by ordering it by:

💻 Visiting: https://okt.to/W7ib3U

✉️ Emailing: prp@patientresource.com

📞 Calling: 800-497-7530